Status and phase
Conditions
Treatments
About
Evaluation of safety and efficacy of Tipranavir (TPV) boosted with Ritonavir (RTV) versus an active control arm (Lopinavir / RTV) in antiretroviral (ARV) therapy naïve HIV-1 infected patients
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Female patients of child-bearing potential who:
Use of investigational medications within 30 days before study entry or during the trial
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal